Nature.com | Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from ... Nature.com The lower manufacturing costs of hyperimmune equine antisera therefore represents an attractive alternate avenue of treatment, especially to developing and third-world countries, compared to the more costly production process of EBOV GP-specific mAbs. |
-
-
Featured
- Breeders’ Cup Connections: “Zurdo” Estrada Happiest With His Horses – Thoroughbred Daily News
- Country rockers A Thousand Horses return to Tulsa Oct. 12 – Cherokee Phoenix
- Theodore Roosevelt National Park to roundup bison and horses for transfer – KFYR
- How to get a horse in Zelda: Echoes of Wisdom – Polygon
- Expert Horse Racing Picks for Belmont and Aqueduct – SportsGrid
Comments
- Ruth on Houston SPCA to seek custody of 8 horses rescued from Brookshire property – KTRK-TV
- Ed on With Hurricane Florence on the way, some horses go while others stay – Virginian-Pilot
- edward on Arizona Hay Report: November 09, 2018
- edward on Shop Arizona Hay
- Vicki Wells on Open to the public: Monty Roberts’ ‘The Movement 2018’ brings equine experts to Solvang – Manhattan Mercury
